GlassScriptPhysician profile
Sandra Laurencin
NPI 1316038847
$4,781.09
in general payments reported to CMS, 2019-2025
38 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2020: $503 · 2021: $728 · 2022: $393 · 2023: $857 · 2024: $1,078 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $800.17 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $544.84 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $324.59 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Insulet Corporation | $262.90 | 2023-2024 | Omnipod |
| Abbvie INC. | $258.89 | 2021-2024 | |
| Mannkind Corporation | $239.06 | 2019-2023 | Afrezza |
| Abbott Laboratories | $223.68 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $219.35 | 2019-2024 | |
| Astellas Pharma US INC | $172.95 | 2020-2024 | Veozah |
| Merck Sharp & Dohme LLC | $159.73 | 2019-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $134.90 | 2019-2021 | |
| Exact Sciences Corporation | $134.77 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $109.16 | 2019-2024 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $97.92 | 2019-2020 | |
| Boston Scientific Corporation | $96.94 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Laurencin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.